Pretreatment with the probiotic VSL#3 delays transition from inflammation to dysplasia in a rat model of colitis-associated cancer

Lignende værker

• The Probiotic VSL#3 Modulates Colonic Macrophages, Inflammation, and Microflora in Acute Trinitrobenzene Sulfonic Acid Colitis
  af: Isidro, Raymond A., et al.
  Udgivet: (2017)
• Gut Microbial Diversity is Reduced by the Probiotic VSL#3 and Correlates with Decreased TNBS-Induced Colitis
  af: Uronis, Joshua M., et al.
  Udgivet: (2011)
• VSL#3 probiotic modifies mucosal microbial composition but does not reduce colitis-associated colorectal cancer
  af: Arthur, Janelle C., et al.
  Udgivet: (2013)
• Erlotinib inhibits progression to dysplasia in a colitis-associated colon cancer model
  af: Pagán, Beatriz, et al.
  Udgivet: (2011)
• The Probiotic Mixture VSL#3 Alters the Morphology and Secretion Profile of Both Polarized and Unpolarized Human Macrophages in a Polarization-Dependent Manner
  af: Isidro, Raymond A., et al.
  Udgivet: (2014)